[1] Yamashita S, Okita K, Harada K, et al. Giant cavernous hepatic hemangioma shrunk by use of sorafenib. Clin J Gastroenterol, 2013, 6:55-62.
[2] 贾科峰,于长路,孙诚,等.不同血供特点肝血管瘤介入治疗的效果及并发症分析.中华肝胆外科杂志,2018,24:145-149.
[3] 朱倩,乔国梁,晏建军,等.对成人肝血管瘤自然发展进程及生长方式的新认识:队列研究.中华肝胆外科杂志,2015,21:721-725.
[4] 别玉坤,冯以斌,杨成林,等.腹腔镜下规则性肝切除与肝肿瘤剥除术治疗肝血管瘤的临床疗效比较.实用癌症杂志,2017,32:1993-1995.
[5] 顾亚奇,余红东.介入栓塞与手术切除治疗巨大肝血管瘤临床疗效对比.肝脏,2015,20:507-509.
[6] Igarashi G, Mikami K, Sawada N, et al. Interventional treatment for giant hepatic hemangioma accompanied by arterio-portal shunt with ascites. Intern Med, 2018, 57:2847-2851.
[7] 吴宝强,安勇,江勇,等.腹腔镜下肝血管瘤剥离技术探讨.肝胆胰外科杂志,2017,29:461-463.
[8] 赵康路,黄玉,叶卫江,等.原发性肝癌肝动脉化疗栓塞术后胆管损伤1例报告.临床肝胆病杂志,2014,30:1204-1205.
[9] 王勋,陈明易,陈永卫,等.外科手术治疗肝脏血管瘤908例临床分析.中华肝胆外科杂志,2018,24:442-445. |
